An official website of the United States government Here’s how you know United States Drug Enforcement Administration SEARCH FULL MENU Main Menu Fulltext Search Advanced Search ENTER KEYWORDS BELOW Filter Results SELECT TO NARROW SEARCH RESULTS Document Type Publication Type Drug Name Topic Clear All Results Administrator Anne Milgram Remarks on ONDCP Press Call Addressing the Overdose Epidemic November 17, 2021 SPEECH DEA’s mission is to keep American communities safe and healthy and we are in the midst of an overdose crisis that has reached a devastating new height. 265 people die every day from drug overdoses. Countless more [people] overdose and are fortunate to survive. This is a national crisis. It... Counterfeit Pills Factsheet September 27, 2021 PUBLICATION What is it? Many counterfeit pills are made to look like prescription opioids – such as oxycodone (Oxycontin®, Percocet®), hydrocodone (Vicodin®), and alprazolam (Xanax®); or stimulants like amphetamines (Adderall®) – but contain fentanyl or methamphetamine. Criminal drug networks are mass-producing fake pills and falsely marketing them as legitimate prescription pills... Laboratory Operations Manual September 01, 2021 PUBLICATION This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and current as of June 21, 2021 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their entirety... Analysis of Drugs Manual June 15, 2021 PUBLICATION This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and current as of March 29, 2021 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their entirety... 2020 National Drug Threat Assessment March 02, 2021 PUBLICATION The 2020 National Drug Threat Assessment (NDTA) is a comprehensive assessment of the threat posed to the United States by the trafficking and abuse of illicit drugs, the diversion and abuse of licit drugs, and the laundering of proceeds generated through illicit drug sales. It also addresses the role domestic... Operation Engage February 24, 2021 PUBLICATION A comprehensive approach that will target the top drug threat identified by the local DEA division while continuing to focus on drug trafficking, violence, and crime reduction. Summary of Validated Methods January 08, 2021 PUBLICATION This document is an internal Drug Enforcement Administration quality system document which provides a summary of validated quantitative and qualitative methods. The document is updated periodically and current as of January 8, 2021, and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted... Illicit Stimulant Availability in Pennsylvania, 2020 December 30, 2020 PUBLICATION Illicit stimulants, specifically cocaine and methamphetamine, remain a pervasive drug threat in Pennsylvania. PFD offices, state/local law enforcement agencies, and other stakeholders throughout Pennsylvania report persistent increases since 2017 in various indicators that demonstrate availability, such as the total quantity of illicit stimulants seized by law enforcement, identification of seized... Illicit Opioid Availability in Pennsylvania 2020 December 30, 2020 PUBLICATION The increasing availability of illicit opioids is the most significant drug threat in Pennsylvania. The Philadelphia Field Division (PFD) monitors this threat closely, periodically reviewing multiple data indicators, in conjunction with investigative information, to continually assess the threat, then share analytical findings with stakeholders in federal, state, and municipal governments. DEA and USPS unveil Drug Free USA Forever stamp October 27, 2020 SPEECH On behalf of the nearly 10,000 men and women of the Drug Enforcement Administration that are serving today across the United States and in nearly 70 countries around the world, I want to welcome the United States Postal Service, and all of you watching via livestream, to DEA Headquarters and... Showing 1 - 10 of 299 results Pagination Current page 1 Page 2 Page 3 Page 4 Next page › Last page » SAMHSA Behavioral Health Treatment Locator Who We Are About Domestic Divisions Foreign Offices Contact Us DEA Museum What We Do Drug Prevention Law Enforcement Diversion Control Division News Careers Overview Special Agent Diversion Investigator Forensic Sciences Intelligence Research Specialist Resources Drug Information Employee Assistance Program Equal Opportunity Employer FOIA Publications Media Galleries VWAP Doing Business with the DEA Overview Current Vendors Prospective Vendors Security Clauses Security Forms Small Business Program Policies Accessibility, Plug-ins & Policy Legal Policies & Disclaimers No FEAR Act Privacy Policy U.S. Department of Justice EEO Policy USA.gov Whistleblower Protection United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice Facebook Twitter LinkedIn Instagram DEA Contact Center (202) 307-1000 info@dea.gov Contact the Webmaster